| SHXYX | VIVIX | SHXYX / VIVIX | |
| Total Expense Ratio | 0.90 | 0.03 | 3,000% |
| Annual Report Gross Expense Ratio | 1.02 | 0.03 | 3,400% |
| Fund Existence | 9 years | 28 years | - |
| Gain YTD | -51.187 | 14.777 | -346% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 100000 | 5000000 | 2% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 23M | 245B | 0% |
| Annual Yield % from dividends | 0.25 | 1.88 | 13% |
| Returns for 1 year | -49.47 | 22.78 | -217% |
| Returns for 3 years | -38.61 | 54.03 | -71% |
| Returns for 5 years | -52.67 | 58.49 | -90% |
| Returns for 10 years | N/A | 158.70 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FSCHX | 14.68 | 0.19 | +1.31% |
| Fidelity Select Chemicals | |||
| MFWLX | 17.93 | 0.19 | +1.07% |
| MFS Global Total Return R6 | |||
| GSPAX | 20.03 | 0.03 | +0.15% |
| Goldman Sachs US Eq Div and Premium A | |||
| BSPAX | 869.26 | 0.03 | N/A |
| iShares S&P 500 Index Investor A | |||
| TRCLX | 19.10 | -0.80 | -4.02% |
| T. Rowe Price China Evolution Equity I | |||